Cancer Genetics, Inc. (CGI) offers products and services that enable personalized cancer diagnosis.

Cancer Genetics, Inc. (CGI), an emerging leader in personalized medicine, offers diagnostic services and products that are improving patient management and reducing healthcare costs. The proprietary tests of CGI's diagnostic lab provide critical genomic information to clinicians to assist with the diagnosis, prognosis, and clinical management of cancer patients. CGI is GLP/GCP and HIPAA compliant, CLIA certified, CAP accredited, and holds licensure in several US States. In addition to di...

Cancer Genetics, Inc. (CGI), an emerging leader in personalized medicine, offers diagnostic services and products that are improving patient management and reducing healthcare costs. The proprietary tests of CGI's diagnostic lab provide critical genomic information to clinicians to assist with the diagnosis, prognosis, and clinical management of cancer patients. CGI is GLP/GCP and HIPAA compliant, CLIA certified, CAP accredited, and holds licensure in several US States. In addition to diagnostic services, CGI also develops and manufactures diagnostic devices for the detection of genomic abnormalities in various hematological malignancies and solid tumors. CGI's diagnostic devices encompass both DNA-FISH probes and microarrays for use in clinical and research laboratories.